EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Complete Improvement of Severe Forearm Complex Regional Pain Syndrome with Six High-Dose Incobotulinumtoxin A Injections: Clinical Implications with Respect to the Literature

Harald Hefter iD, Marek Moll, Sara Samadzadeh iD

Toxins · 2024

DOI: 10.3390/toxins16110488 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Toxins, 2024. Verfasst von Harald Hefter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Forearm, Neuromuscular Agents. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is some evidence that injections of botulinum neurotoxin effectively reduce pain in complex regional pain syndromes (CRPSs). But no or little experience appears to exist for the application of incobotulinum neurotoxin type A (incoBoNT/A) in complex pain disorders. Here, a case of CRPS type I, characterized by severe symptoms in the left forearm is presented, showed significant continuous improvement following a series of six repetitive (painful) injections into the finger, hand, and forearm muscles of incoBoNT/A every 3 months, administered at declining doses varying between 500 and 100 U. Remarkably, this treatment regimen led to the complete resolution of pain, vaso- and sudomotor symptoms, and hand dystonia. This highlights the possible efficacy of incoBoNT/A in the treatment of CRPS and encourages the further exploration of incoBoNT/A’s role in the successful management of complex pain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AForearmNeuromuscular AgentsHumansComplex Regional Pain SyndromesFemaleInjections, IntramuscularTreatment OutcomeMaleAdultReflex Sympathetic DystrophyMiddle Aged

Stichwörter der Autor:innen

botulinum toxincomplex regional pain syndromedystoniaincobotulinum neurotoxin type Alow antigenicity

Substanzen

Botulinum Toxins, Type AincobotulinumtoxinANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Neurology, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, 13125 Berlin, Germany.
  • Department of Regional Health Research and Molecular Medicine, University of Southern Denmark, 5230 Odense, Denmark.
  • Department of Neurology, Slagelse Hospital, 4200 Slagelse, Denmark.

ORCID-Profile: Harald Hefter, Sara Samadzadeh

Zitieren

APA

Hefter, H., Moll, M., & Samadzadeh, S. (2024). Complete Improvement of Severe Forearm Complex Regional Pain Syndrome with Six High-Dose Incobotulinumtoxin A Injections: Clinical Implications with Respect to the Literature. Toxins. https://doi.org/10.3390/toxins16110488

Vancouver

Hefter H, Moll M, Samadzadeh S. Complete Improvement of Severe Forearm Complex Regional Pain Syndrome with Six High-Dose Incobotulinumtoxin A Injections: Clinical Implications with Respect to the Literature. Toxins. 2024. doi:10.3390/toxins16110488

BibTeX
@article{Hefter2024,
  author = {Hefter, Harald and Moll, Marek and Samadzadeh, Sara},
  title = {Complete Improvement of Severe Forearm Complex Regional Pain Syndrome with Six High-Dose Incobotulinumtoxin A Injections: Clinical Implications with Respect to the Literature},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16110488}
}
Kostenlos starten →